Tue, Nov 26, 2024
Volume 18, Issue 2 (Mar-Apr 2024)
mljgoums 2024, 18(2): 19-21 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Chandrika C, Jayan A, Beevi Osman F. The correlation between serum leptin levels and lipid profile among non-obese type 2 diabetes mellitus patients and non-diabetic individuals. mljgoums 2024; 18 (2) :19-21
URL: http://mlj.goums.ac.ir/article-1-1550-en.html
URL: http://mlj.goums.ac.ir/article-1-1550-en.html
1- Government Medical College, Thiruvananthapuram, Kerala, India , drchandralekshmy26@gmail.com
2- Government Medical College, Thiruvananthapuram, Kerala, India
3- Department of Biochemistry, Government Medical College, Thiruvananthapuram- Kerala, India
2- Government Medical College, Thiruvananthapuram, Kerala, India
3- Department of Biochemistry, Government Medical College, Thiruvananthapuram- Kerala, India
Abstract: (709 Views)
Background: Type 2 DM is a heterogeneous group of disorders characterized by insulin resistance, impaired insulin secretion, increased glucose production, and abnormal fat metabolism. Diabetes mortality primarily results from microvascular complications such as diabetic retinopathy, nephropathy, and neuropathy, as well as macrovascular complications like coronary artery, peripheral vascular, and cerebrovascular diseases. Patients with diabetes usually have changes in adipose tissue metabolism and abnormalities in the secretion of adipokines such as leptin. The present study aims to study the relationship between serum leptin levels and lipid profile parameters among non-obese type 2 diabetes mellitus patients and non-diabetic individuals.
Methods: This hospital-based cross-sectional study was conducted among 41 type 2 diabetic patients and 41 non-diabetic individuals of both sexes between the ages of 40 and 70. Fasting blood glucose (FBS), serum leptin, total cholesterol (TC), triglyceride (TG), and high-density lipoprotein (HDL) levels were assayed.
Results: The mean serum leptin levels among diabetic patients were lower than those of non-diabetic individuals, and this difference in mean was statistically significant. The study showed a significant negative correlation between serum leptin, TC, TG, and low-density lipoprotein (LDL), and a positive correlation with HDL. In the final regression model, serum leptin showed a statistically significant association with FBS and HDL.
Conclusion: This study demonstrated that serum leptin levels can be a strong predictor of low HDL levels in diabetic patients. It can also contribute to raised levels of total cholesterol, triglyceride, and LDL, which are responsible for macrovascular complications in diabetics.
Methods: This hospital-based cross-sectional study was conducted among 41 type 2 diabetic patients and 41 non-diabetic individuals of both sexes between the ages of 40 and 70. Fasting blood glucose (FBS), serum leptin, total cholesterol (TC), triglyceride (TG), and high-density lipoprotein (HDL) levels were assayed.
Results: The mean serum leptin levels among diabetic patients were lower than those of non-diabetic individuals, and this difference in mean was statistically significant. The study showed a significant negative correlation between serum leptin, TC, TG, and low-density lipoprotein (LDL), and a positive correlation with HDL. In the final regression model, serum leptin showed a statistically significant association with FBS and HDL.
Conclusion: This study demonstrated that serum leptin levels can be a strong predictor of low HDL levels in diabetic patients. It can also contribute to raised levels of total cholesterol, triglyceride, and LDL, which are responsible for macrovascular complications in diabetics.
Research Article: Original Paper |
Subject:
Biochemistry
Received: 2022/07/16 | Accepted: 2024/02/21 | Published: 2024/04/30 | ePublished: 2024/04/30
Received: 2022/07/16 | Accepted: 2024/02/21 | Published: 2024/04/30 | ePublished: 2024/04/30
References
1. Henry M Kronberg, Shlomo Melmed. Williams Text book of endocrinology. 2007;11:1567-78. [View at Publisher] [Google Scholar]
2. Faerch K, Vaag A, Holst J J, Hansen T, Jorgensen. T, Borch-Johnson K. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter 99 Study. Diabetes Care. 2009; 32:439 - 444. [View at Publisher] [DOI:10.2337/dc08-1195] [PMID] [Google Scholar]
3. Karam JH. Reversible insulin resistance in non-insulin-dependent diabetes mellitus. Horm Metab Res. 1996; 28(9):440-4. [View at Publisher] [DOI:10.1055/s-2007-979834] [PMID] [Google Scholar]
4. Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, Sturis J. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 1995; 44(5): 506-12. [View at Publisher] [DOI:10.2337/diabetes.44.5.506] [PMID] [Google Scholar]
5. Iqbal MP, Shafiq M. Hypertriglyceridemia and low HDL-Cholesterol are the major lipid abnomalities in Diabetes mellitus. Pak. J. Med. Sci. 2004; 20: 385-91. [View at Publisher] [Google Scholar]
6. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS. 2006; 580:2917-2921. [View at Publisher] [DOI:10.1016/j.febslet.2006.04.028] [PMID] [Google Scholar]
7. Wang MY, Koyama K, Shimabukuro M, Mangelsdorf D, Newgard CB, Unger RH. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc Natl Acad Sci U S A. 1998; 95(20): 11921-6. [View at Publisher] [DOI:10.1073/pnas.95.20.11921] [PMID] [Google Scholar]
8. Wang MY, Lee Y, Unger RH. Novel form of lipolysis induced by leptin. J Biol Chem. 1999; 274(25): 17541-4. [View at Publisher] [DOI:10.1074/jbc.274.25.17541] [PMID] [Google Scholar]
9. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340: 115-126. [View at Publisher] [DOI:10.1056/NEJM199901143400207] [PMID] [Google Scholar]
10. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1994; 14(5): 840-56. [View at Publisher] [DOI:10.1161/01.CIR.89.5.2462] [PMID] [Google Scholar]
11. Chandralekshy C, Fathima Beevi.O. A comparative study of serum leptin levels among type 2 diabetes mellitus patients and non-diabetic individuals – hospital based cross- sectional study in Thiruvanthpuram, Kerala. Global Journal of Medicine & Public Health. 2023; 12(1):1-8. [View at Publisher]
12. Roden M, Ludwig C, Nowotny P, Schneider B, Clodi M, Vierhapper H, et al. Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes Relat Metab Disord. 2000; 24(8): 976-81. [View at Publisher] [DOI:10.1038/sj.ijo.0801266] [PMID] [Google Scholar]
13. Moriyo M, Okumura T, Takahashi N, Yamagata K, Motomura W, Kohgo Y. An inverse correlation between serum leptin levels and hemoglobin A1c in patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract. 1999;43(3):187-91. [View at Publisher] [DOI:10.1016/S0168-8227(99)00013-3] [PMID] [Google Scholar]
14. Tuominen JA, Ebeling P, Stenman UH, Heiman ML, Stephens TW, Koivisto VA. Leptin synthesis is resistant to acute effects of insulin in insulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab. 1997; 82(2): 381-2. [View at Publisher] [DOI:10.1210/jc.82.2.381] [PMID] [Google Scholar]
15. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes. 1996; 45(6):822-4.
https://doi.org/10.2337/diabetes.45.6.822 [View at Publisher] [DOI:10.2337/diab.45.6.822] [PubMed] [Google Scholar]
16. Lee ZS, Chan JC, Yeung VT, Chow CC, Lau MS, Ko GT, et al. Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care. 1999; 22(9): 1450-7. [View at Publisher] [DOI:10.2337/diacare.22.9.1450] [PMID] [Google Scholar]
17. Hirose H, Saito I, Kawai T, Tsujioka M, Kawabe H, Saruta T. Relationships between baseline serum leptin levels and 2-year changes in body mass index, blood pressure and metabolic parameters in Japanese male adolescents and middle-aged men. Clin Sci (Lond). 2001; 100(2): 145-50. [View at Publisher] [DOI:10.1042/cs1000145] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.